Studies on the underlying mechanisms demonstrate that activation of HER3-initiated signaling facilitates tumor progression mainly through enhanced metastatic potential of cancer cells and induced resistance to treatments [26–29]. The gene discussed is ERBB3; the disease is neoplasm.